Stroke Trial, Recruiting NCT07638462 Sponsor: Wake Forest University Health Sciences Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07638462
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who are currently admitted to hospital with an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain)
  • People whose stroke severity, measured by a standard medical scale called the NIHSS, scored 10 or higher at the time of admission
  • People who, before this stroke, had little to no disability, as measured by a standard scale called the modified Rankin Scale (a score of 0–2)
  • People who currently have a moderate to moderately severe level of disability as a result of the stroke, as measured by the same scale (a score of 3–5)

Who may not be able to join:

  • People who are currently having, or are expected to have, end-of-life care discussions
  • People for whom surgery is currently planned
  • People who already had significant disability before this stroke (a modified Rankin Scale score of 3–5 prior to the stroke)
  • People with a bone, muscle, joint, or skin injury that would make it unsafe to stand, move around, or use mobility equipment
  • People with heart or breathing conditions that are not currently under control
  • People with seizures that are active or not currently under control
  • People in isolation conditions that prevent movement outside of their hospital room
  • People whose body weight exceeds the safe weight limit of the mobility equipment used in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rahul Karamchandani, MD, Wake Forest University Health Sciences

Phone: 704-355-7403

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 July 2026
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Achievement of the Johns Hopkins Highest Level of Mobility (JH-HLM) goal based on the Activity Measure for Post-Acute Care (AM-PAC) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov